As part of our legal practice, we modelled the legal process for selling OTC drugs for corporate entities, including global enterprises with nearly a hundred years of history.
We also advised on the placing of medical products and devices from the United States of America on the European market as well as on trading in such products using e-sales platforms. We have represented numerous entities in disputes regarding the quality standards of products and medical devices imported from the People’s Republic of China (during the COVID-19 pandemic, for example).
Thanks to our experience, we are able to identify potential legal threats or technical problems related to business models at the very beginning of cooperation.